期刊文献+

某社区帕金森患者认知及情感特征调查 被引量:3

The Investigation of Congitive and Mofional Deficits in Parkinson's Disease Patients
暂未订购
导出
摘要 目的:调查某社区帕金森患者轻度认知障碍(MIC),抑郁、焦虑的发生率。分析轻度认知障碍及抑郁发生的影响因素。方法:对五华县河东镇五家医院107例门诊、住院帕金森病患者进行蒙特利尔认知评估(MoCA)简易精神状态表(MMSE)及神经心理量表、汉密顿抑郁量表(HRSD)、焦虑量表(HAMA)测试,统一帕金森评分量表(UPDRS),统计MIC、抑郁、焦虑的发生率。结果:MoCA评价认识功能障碍发生率为82.2%,抑郁、焦虑的发生率为65%,48%。轻度认知障碍发生以抑郁、焦虑程度有关。但其影响因素有教育、病情严重程度、年龄,而抑郁、焦虑的影响无统计学意义。结论:帕金森患者多合并轻度认知障碍及抑郁、焦虑情绪。MoCA对轻度认知障碍的评价有较高的敏感性。 Objective:To investigate the incidence of mild congitive deficits and motional deficits in guangzhou, and analyse the influence of the factor on MIC, depression. Method: A total of 107 PD patients was drawn randomly in five hospitals , had completed MoCA, MMSE, neuropsychological tests (NPT) , Hamilton Depression Scal( HRSD ), Hamilton Anxiety Scale ( HAMA ). The incidence of MIC, dpression, anxiety was analysed. Result: The incidence of MIC,depression,anxiety was 82.2% ,65% ,48%. MIC was correlati to depression and anxiety. The factors that influence the MIC was education level,UPDRS and age. Conclusion: Most of Parkinson's disease patients had congitive deficits, and depression, anxiety. MIC is difficult to be found by MMSE, MoCA is a breif congition screening tool with high sensitivity for detecting MIC in PD patients, but not to make formal diagnose.
作者 谢志灵
出处 《河北医学》 CAS 2009年第5期579-582,共4页 Hebei Medicine
关键词 帕金森病 蒙特利尔认知评估 认知障碍 抑郁 焦虑 Parkinson's disease Montreal congitive assessment Congitive disorders Depression Anxiety
  • 相关文献

参考文献5

  • 1Mohr E,Mendis T,Grimes G D.Late cognitive change in Parkinson's disease withan emphasis on dementia[M].Winer W J.Behavioral neurology of moyment disorder.New York:Raven Press,1995.97-105.
  • 2陈生弟,谭玉燕.帕金森病的认知功能障碍不容忽视[J].老年医学与保健,2006,12(4):202-205. 被引量:3
  • 3Wind A W,Schellevis F G,Van Staveren G,et al.Limitations of the Mini-Mental State Examination in diagnosing dementia in general practice[J].Int Gefiatr Psychiatry,1997,12:101-108.
  • 4温洪波,张振馨,牛富生,李凌.北京地区蒙特利尔认知量表的应用研究[J].中华内科杂志,2008,47(1):36-39. 被引量:357
  • 5Hughes T A,Ross H F,Musa S,et al.A 10-year study of the incidence of and factors preicting dementia in Parkinson's disease[J].Neurology,2000,54:1596-1602.

二级参考文献22

  • 1Aarsland D,Zaecai J,Brayne C.A systematic review of prevalence studies of dementia in Parkinson's disease.Mov Disord,2005,20:1255~1263.
  • 2Adler CH.Nonmotor complications in Parkinson's disease.Mov Disord,2005,20 Suppl 11:S23~29.
  • 3Bruck A,Kurki T,Kaasinen V,et al.Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment.J Neurol Neurosurg Psychiatry,2004,75:1467~1469.
  • 4Papapelropoulos S,Lieherman A,Gonzalezl J,et al.Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease.Acta Neurol Scand,2005,111:353~359.
  • 5Jellinger KA,Seppi K,Wenning GK,et al.Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease.J Neural Transm,2002,109:329~339.
  • 6Collerton D,Burn D,McKeith I.Systematic review and metaanalysis show that dementia with Lewy bodies is a visual perceptual and attentional-executive dementia.Dement Geriatr Cogn Disord,2003,16:229~237.
  • 7Marinus J,Visser M,Verwey NA,et al.Assessment of cognition in Parkinson's disease.Neurology,2003,61:1222~1228.
  • 8Poewe W.The need for neuroprotective therapies in Parkinson's disease:a clinical perspective.Neurology,2006,66:S2~9.
  • 9Cools R.Dopaminergic modulation of cognitive funetion-implications for L-DOPA treatment in Parkinson's disease.Neurosci Biobehav Rev,2006,30:1~23.
  • 10Leiva-Santana C,Alvarez-Sauco M.Levodopa and cognitive disorders in Parkinson's disease.Rev Neurol,2006,43:95~100.

共引文献358

同被引文献44

  • 1周盛年,韩恩吉,赵庆胜,陈耀民,魏先森,万琪,刘永红,张镛,崔元孝,马丕林.单唾液酸四己糖神经节苷脂治疗急性脑梗死随机双盲对照多中心研究[J].中国新药与临床杂志,2005,24(11):880-883. 被引量:53
  • 2张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:619
  • 3方乃成,赵明,金星火,王马军,江基尧(点评).超低位大骨瓣开颅颞肌下减压术治疗重型颅脑创伤脑疝病人[J].中华神经外科杂志,2006,22(10):612-614. 被引量:57
  • 4王拥军.神经病学临床评定量表[M].北京:中国友谊出版公司,2005,6.
  • 5Gill DJ, Freshman A, Blender JA, et al. The Montreal Cogni- tive Assessment as a screening tool for cognitive impairment in Parkinson's disease [J]. Mov Disord, 2008, 23(7): 1043-1046.
  • 6Aarsland D, Andersen K, Larsen JP, et al. Prevalence and char- acteristics of dementia in Parkinson disease: an 8-year prospec- tive study [J]. Arch Neurol, 2003, 60: 387-392.
  • 7Nasreddine ZS, Phillips NA, BedirianV, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment [J]. J Am Geriatr Soc, 2005, 53(4): 695-699.
  • 8Smith T, Gildeh N, Holmes C. The Montreal Cognitive Assess- ment: validity and utility in a memory clinic setting [J]. Can J Psychiatry, 2007, 52(5): 329-332.
  • 9Gelb D J, Oliver E, Gilman S. Diagnostic criteria for Parkin- son's disease [J]. Arch Neurol, 1999, 56: 33-39.
  • 10Folstein MF, Folstein SE, McHugh PR. "Mini-mental state . A practical method for grading the cognitive state of patients for the clinician [J]. J Psychiatr Res, 1975, 12: 189-198.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部